Related Articles
Survival after cytotoxic chemotherapy in patients with advanced hormone-resistant prostate cancer: A phase II study
Long-term survival of patients with advanced colorectal cancer may not be due to the response to chemotherapy
Interleukin-2 and interferon alpha 2 combination
Paclitaxel and carboplatin in pretreated advanced gastric cancer: A phase II study
Paclitaxel and liposomal doxorubicin (Caelyx) combination in advanced breast cancer patients: a Phase II study